Article Information
History
- August 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Tobias Brünger1,+,
- Alina Ivaniuk2,+,
- Eduardo Pérez-Palma3,
- Ludovica Montanucci2,4,
- Stacey Cohen5,6,7,
- Lacey Smith8,
- Shridhar Parthasarathy5,6,7,
- Ingo Helbig5,6,7,9,
- Michael Nothnagel1,
- Patrick May10 and
- Dennis Lal1,2,4,11,12,13,*
- 1Cologne Center for Genomics (CCG), University of Cologne, Cologne, 50931, Germany
- 2Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA
- 3Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana. Santiago, Chile
- 4Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, OH 44106, USA
- 5Division of Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
- 6The Epilepsy NeuroGenetics Initiative (ENGIN), Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 7Department of Biomedical and Health Informatics (DBHi), Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
- 8Epilepsy Genetics Program, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children’s Hospital, Boston, MA, USA
- 9Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 10Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
- 11Stanley Center of Psychiatric Research, Broad Institute of Harvard and MIT, 75 Ames Street, Cambridge, 02142, MA, USA
- 12Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44106, USA
- 13Center for Neurogenetics, The University of Texas Health Science Center at Houston, Houston, TX
- ↵*Corresponding author. Email: dennis.lal{at}uth.tmc.edu
↵+ Authors contributed equally to this work
Posted August 24, 2023.
Pathogenic paralogous variants can be used to apply the ACMG PS1 and PM5 variant interpretation criteria
